Anti-osteoporosis agent-8
Anti-osteoporosis agent-8 (Compound 4aa) is an inhibitor for RANKL, which inhibits RANKL-induced osteoclastogenesis and osteoclast differentiation (IC50 is 2.41 μM) in cells RAW264.7. Anti-osteoporosis agent-8 ameliorates bone loss in an ovariectomized (OVX) mice model.
For research use only. We do not sell to patients.
- CAS No.: 3036050-96-8
- Formula: C18H19F3N2O2Se
- Molecular Weight:431.31
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BMMC | IC50 |
2.41 μM
Compound: 4aa
|
Anti-osteoclastogenesis activity in M-CSF/RANKL-induced C57BL/6 mouse BMMC cells assessed as inhibition of osteoclasts formation incubated for 6 days with media replacement for every 2 days by TRAP-staining based light microscopic analysis
Anti-osteoclastogenesis activity in M-CSF/RANKL-induced C57BL/6 mouse BMMC cells assessed as inhibition of osteoclasts formation incubated for 6 days with media replacement for every 2 days by TRAP-staining based light microscopic analysis
|
[PMID: 38630440] |
Anti-osteoporosis agent-8 (0-10 μM, 5 days) promotes osteoblast differentiation in cells MC3T3-E1 through activation of BMP2 signaling pathway[1].
Anti-osteoporosis agent-8 (5 μM, 6 h) inhibits the osteoclast-related genes expression, osteoclastogenesis, and osteoclastic bone resorption, though inhibition of MAPK and NF-κB-signaling pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ovariectomized C57BL/6 mice model[1]
-
Dosage:10 mg/kg
-
Administration:i.p., every other days, for 8 weeks
-
Result:Reduced the bone loss, increased bone volume/total bone volume, trabecular thickness and trabecular number, without significant toxicity in mainly organs.
Chemical Information
-
CAS No. 3036050-96-8
-
Molecular Weight 431.31
-
Formula C18H19F3N2O2Se
-
SMILES
O=C(NC1=CC=NC=C1)C([Se]C2=CC=CC=C2)C(C)(OCC(F)(F)F)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anti-osteoporosis agent-8 Related Classifications
HY-158311 Related Classifications
Powered by Bioz